A SUMOylation/immune-related gene signature predicts the prognosis and immunotherapy efficacy of patients with triple-negative breast cancer. [PDF]
Zou P +5 more
europepmc +1 more source
ABSTRACT Background To define the role of post‐mastectomy radiotherapy (PMRT) in triple‐negative breast cancer (TNBC), employing lymph node ratio (LNR, ratio of positive over excised lymph nodes) to offer personalized treatment strategies for this aggressively behaving cancer type. Methods The study included a total of 6474 women diagnosed with T1‐4 N1‐
Wei‐Hong Zheng +6 more
wiley +1 more source
Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer. [PDF]
Vuong NB +10 more
europepmc +1 more source
ABSTRACT The efficacy of PD‐1 inhibitor pucotenlimab (HX008) in solid tumors exhibits heterogeneity. This study integrated data from 6 clinical trials (covering gastric/gastroesophageal junction cancer, triple‐negative breast cancer, melanoma, and dMMR/MSI‐H solid tumors) using Bayesian meta‐analysis, machine learning (optimal XGBoost AUC = 0.86), and ...
Yingge He +6 more
wiley +1 more source
Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer. [PDF]
Lee DK +20 more
europepmc +1 more source
Defensins are a large and ancient family of host–defence peptides present across vertebrates, invertebrates, and plants, where they play a crucial role in innate immunity. Among them, big defensins represent a structurally distinctive subfamily characterized by a hydrophobic N‐terminal domain and a cysteine‐rich C‐terminal β‐defensin‐like domain. Here,
Rita Turnaturi +12 more
wiley +1 more source
Peripheral Blood IL-6 and STAT3 Gene Expression as Biomarkers Associated with Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer: A Prospective Cross-Sectional Study. [PDF]
Özdemir K +5 more
europepmc +1 more source
• STK25 deficiency enhanced CAF‐mediated CRC growth via the NF‐κB/AREG/EGFR axis. • STK25 overexpression or AREG antibody overcame CAF‐mediated cetuximab resistance. • CRC patients with high STK25 and low CAFs marker levels might benefit from cetuximab treatment.
Yifan Hou +17 more
wiley +1 more source
A multiparametric magnetic resonance imaging model incorporating the relative apparent diffusion coefficient for preoperative discrimination of triple-negative breast cancer. [PDF]
Fan H +9 more
europepmc +1 more source
TNBC invasion: downstream of STAT3
Jackson, James G., Lozano, Guillermina
openaire +1 more source

